http://www.biospace.comBioSpace RSS GeneratorSat, 25 May 2013 13:34:26 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.chinabiotoday.com/articles/20130410by Richard Daverman, PhD</p><p>April 10, 2013 -- Tong Ren Tang Technologies Co., a maker of Traditional Chinese Medicines, is moving forward on its long-term plan to spin off and IPO a subsidiary, TRT Chinese Medicine, on the ChiNext exchange, probably within the next three months. TRT Chinese Medicines is Chinas largest exporter of TCM products. Details of the offering are not yet available...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.bizjournals.com/boston/blog/bioflash/2013/03/tetraphase-enanta-prepare-for-ipos.html?ana=otjTwo Boston-area biotech companies one working on a treatment for hepatitis C, the other aimed at drugs to treat disease caused by bacterial biothreat pathogens are set to raise a combined total of $146 million through two initial public offerings during the week starting March 18. According to Renaissance Capital, Enanta Pharmaceuticals Inc. in Watertown, Mass., and Tetraphase Pharmaceuticals Inc...Tue, 19 Mar 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20130115by Richard Daverman, PhD</p><p>January 14, 2013 -- China National Biotech, the largest biotech in China, is once again reported to be planning a Hong Kong IPO, though the company has not made a formal announcement of the transaction. According to sources, the IPO will raise $1.5 billion. The tentative scheduling is for CNBG to file by the end of March, with the actual transaction taking place in...Tue, 15 Jan 2013 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20120526by Richard Daverman, PhD</p><p>May 25, 2012 -- Yantai Dongcheng Biochemicals has completed a $110 million IPO on Shenzhens Small and Medium-Sized Enterprises Board. The main products from Dongcheng Biochemicals, which makes APIs and finished products, are heparin sodium and chondroitin sulphate, a dietary supplement that treats osteoarthritis. More details....</p><p>Stock Symbol: (SHE: 0...Tue, 29 May 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20120208_1February 8, 2012 -- Shanghai Fosun Pharma's on-again/off-again Hong Kong IPO is apparently now scheduled to take place early this year. According to an unnamed insider, the company has filed its listing application with the Hong Kong exchange. Fosun hopes to raise between $600 million and $800 million by floating up to a 20% stake in the company. More details....</p><p>Stock Symbol: (SHA: 600...Thu, 09 Feb 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20111205_1December 5, 2011 -- Lanzhou Foci Pharma will issue 20.2 million shares in its IPO on the Shenzhen Small and Medium Enterprise Exchange. The expected date is December 13th. The new shares will comprise 25% of the companys post-IPO capitalization of 80.8 million shares. Founded in Shanghai in 1929, Foci Pharma mainly sells and distributes patented TCMs, although it also deals in western drugs and raw...Tue, 06 Dec 2011 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20111104_1November 4, 2011 -- China National Biotechnology Group (CNBG) plans a Hong Kong IPO, according to Zhiping Song, Chairman of its parent, China National Pharmaceutical Group Corporation (SinoPharm Group). CNBG, which will change its name to China Biotech, is comprised of six institutes of biological products. So far, no predictions of the size of the offering have been published. More details....Mon, 07 Nov 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/07/12/novartis-china-ipo-idUSL3E7IB16L20110712Swiss drugmaker Novartis AG could soon be in the position to go for deals again after its $51 billion buy of U.S.-listed eyecare group Alcon, the group's chief executive was quoted as saying on Monday. CEO Joe Jimenez said paying down Novartis' debt of $22 billion was the group's first priority but that it should be able to do this quickly thanks to its strong cash flow. "We could soon be in the position...Tue, 12 Jul 2011 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20110622_1June 22, 2011 -- Shandong Jincheng Pharmaceutical and Chemical completed a 465 million RMB ($72 million) IPO on Shenzhens GEM exchange. The company issued 25 million shares at 18.6 yuan each, a price that reflects a P/E ratio of 22.7. Jincheng Pharma makes cephalosporin intermediates. It plans to use the proceeds of the offering to expand its production capacity. More details....</p><p>Stock Symbol...Wed, 22 Jun 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/05/03/us-shanghaipharmaipo-idUSTRE74217L20110503Bloomberg -- Shanghai Pharmaceuticals Holding Co., Chinas second-largest drug distributor, will sell new shares to Temasek Holdings Pte and Pfizer Inc. (PFE) in an offering in Hong Kong of as much as $2.2 billion of stock to fund acquisitions.</p><p>Temasek, a Singapore state investment company, Pfizer, Guoco Group and Bank of China Group Investment will buy a total of $550 million shares for...Tue, 03 May 2011 12:00:00 AM GMThttp://online.wsj.com/article/SB10001424052748703806304576232560144660964.html?mod=dist_smartbriefWSJ -- Appetite for Israeli initial public offerings of life-science companies is booming, but critics say the sector is immature and lacks the transparency for investors to make informed decisions.</p><p>The first three months of 2011 have brought four life-sciences IPOs, and several more are planned for the first half of the year. The rate so far has been far ahead of that of the past three years...Fri, 01 Apr 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=211379&full=1<div id"releaseBody"><p>PHILADELPHIA, PA and REHOVOT, ISRAEL--(Marketwire - February 22, 2011) - <b>Rosetta Genomics, Ltd. </b>(NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerROSG">ROSG</a>) today announced the closing of an initial public offering (IPO) of its majority-owned subsidiary, Rosetta Green, in Israel which raised gross proceeds of 21,900,960 NIS ($6.06 million). Shares...Tue, 22 Feb 2011 12:00:00 AM GMThttp://www.reuters.com/article/2011/02/08/philogen-ipo-idUSLDE7171XP20110208ZURICH, Feb 8 (Reuters) - Swiss-Italian biotech group Philogen said it plans to debut on the Milan stock exchange later this month, in Europe's first biotech initial public offering in 2011 and the latest sign appetite for the sector is warming.Thu, 10 Feb 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=208288&full=1KUWAIT--(Marketwire - 01/20/11) - Al-Dorra Holdings, a privately held Kuwaiti company, announced today the intent to IPO its newly formed subsidiary Hail First Pharma Inc. in the first quarter of this year.</p><p>According to the company, Hail First Pharma Inc. is the result of several acquisitions and or joint-ventures with international pharmaceutical companies including but not limited to Spencer...Fri, 21 Jan 2011 12:00:00 AM GMThttp://www.scripintelligence.com/business/Indias-Claris-plans-66-million-IPO-306371Economic Times -- Ahmedabad-based critical care and hospital products maker, Claris Lifesciences Ltd , has finally received approval from Securities and Exchange Board of India (SEBI) for its maiden public issue to raise Rs 300 crore. Tue, 23 Nov 2010 12:00:00 AM GMThttp://www.reuters.com/article/idCNTOE6AB09820101112?rpc=44TOKYO, Nov 12 (Reuters) - Japanese drugmaker Otsuka Holdings plans to sell about $2.8 billion worth of shares in December, marking the world's largest initial public offering in the pharmaceuticals sector.Fri, 12 Nov 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=198849&full=1COPENHAGEN, Oct 21 (Reuters) - Zealand Pharma's owners are considering floating part of the Danish biotech firm on the Copenhagen bourse in November, sources said.Thu, 21 Oct 2010 12:00:00 AM GMThttp://www.pharmatimes.com/Article/10-09-01/Russia_s_Pharmsynthez_plans_%C2%A310_5_million_IPO.aspxPharma Times -- Russia's Pharmsynthez has unveiled plans to float on the Moscow Interbank Currency Exchange (MICEX) to help fund a new facility and international expansion.Wed, 01 Sep 2010 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20100521CapitalVue News -- May 14 -- Sichuan Kelun Pharmaceutical, one of the largest manufacturers of intravenous solutions (IV solutions) in the world, plans to issue 60 million A-shares or 25 percent of its enlarged share capital in its initial public offering (IPO), reports China Securities Journal, citing the company's prospectus. Fri, 21 May 2010 12:00:00 AM GMThttp://www.reuters.com/article/idCNN0317800820100203?rpc=44<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Thu, 04 Feb 2010 12:00:00 AM GMThttp://www.rttnews.com/Content/BreakingNews.aspx?Node=B1&Id=1153167%20&Category=Breaking%20News<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Thu, 10 Dec 2009 12:00:00 AM GMThttp://www.reuters.com/article/rbssHealthcareNews/idUSLK59443320091120<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 20 Nov 2009 12:00:00 AM GMThttp://www.reuters.com/article/marketsNews/idINHKG28428220090904?rpc=44<!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...Fri, 04 Sep 2009 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=153326&full=1 <!-- AddThis Button BEGIN --><script type"text/javascript">var addthis_pub"bdwyer";</script><a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"><img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...Mon, 17 Aug 2009 12:00:00 AM GMThttp://www.interfax.cn/news/10668/ChinaBioToday -- Cheezheng Tibetan Medicine Co. has been approved to IPO on the Shenzhen exchange. It will offer up to 41 million shares in the offering. The approval gives evidence that the IPO market in China is continuing to open for life science companies, following the almost year-long absence of any activity as worldwide financial markets imploded. Established in 1992, Cheezheng Tibetan was the...Thu, 13 Aug 2009 12:00:00 AM GMThttp://economictimes.indiatimes.com/stocks_in_news_home/Chemcel_Biotech_IPO_to_open_on_Sep_9/articleshow/3459587.cmsMUMBAI: Chemcel Biotech Ltd, currently engaged in manufacturing of agrochemicals and plans to expand into bio-diesel business, is entering the capital market with its initial public offer of 1,54, 00,000 equity shares of Rs 10 each at a premium of Rs 6 per share. Mon, 08 Sep 2008 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20080827August 27, 2008 -- Last week, The South China Morning Post reported that the China National Pharmaceutical Group (Sinopharm) and CITIC Pharmaceutical Group plan IPOs. The Sinopharm offering would raise up to $750 million. The article said Sinopharms IPO would take place in Q4, and the shares would be listed on the Hong Kong exchange. Sinopharm, a state-owned enterprise, is the largest pharmaceutical...Wed, 27 Aug 2008 12:00:00 AM GMT